Azosulfamide

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 598670

CAS#: 133-60-8

Description: Azosulfamide is an azo compound with antibacterial effect similar to that of sulfanilamide.


Chemical Structure

img
Azosulfamide
CAS# 133-60-8

Theoretical Analysis

MedKoo Cat#: 598670
Name: Azosulfamide
CAS#: 133-60-8
Chemical Formula: C18H14N4Na2O10S3
Exact Mass: 0.00
Molecular Weight: 588.480
Elemental Analysis: C, 36.74; H, 2.40; N, 9.52; Na, 7.81; O, 27.19; S, 16.34

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Azosulfamide; NSC 402615; NSC-402615; NSC402615; Streptozon II; Streptozon S; Disodium Neoprontosil;

IUPAC/Chemical Name: sodium (E)-6-acetamido-4-hydroxy-3-((4-sulfamoylphenyl)diazenyl)naphthalene-2,7-disulfonate

InChi Key: YAZZWQFMIGUHKS-ZPZFBZIMSA-L

InChi Code: InChI=1S/C18H16N4O10S3.2Na/c1-9(23)20-14-8-13-10(6-15(14)34(27,28)29)7-16(35(30,31)32)17(18(13)24)22-21-11-2-4-12(5-3-11)33(19,25)26;;/h2-8,24H,1H3,(H,20,23)(H2,19,25,26)(H,27,28,29)(H,30,31,32);;/q;2*+1/p-2/b22-21+;;

SMILES Code: O=S(C1=C(/N=N/C2=CC=C(S(=O)(N)=O)C=C2)C(O)=C3C=C(NC(C)=O)C(S(=O)([O-])=O)=CC3=C1)([O-])=O.[Na+].[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 588.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: MEONI S, BRUCOLI V, BIAGI G. [THE AZOSULFAMIDE TEST AS A LIVER FUNCTION TEST]. Fegato. 1963 Dec;18:421-31. Italian. PubMed PMID: 14117141.

2: MOLLERBERG HL, BOTTIGER LE. The azosulfamide (neoprontosii) test in clinical evaluation of liver function. AMA Arch Intern Med. 1959 Jun;103(6):949-53. PubMed PMID: 13648997.

3: ORREGO H, TAG F, PALMA R, INZUNZA I, NAVIA E. [Diagnostic value of the urinary excretion of azosulfamide in hepatic diseases]. Rev Med Chil. 1962 Mar;90:230-8. Spanish. PubMed PMID: 14482351.

4: BEGRUP H, HALD A, LINDAHL A. [Liver function test with azosulfamide]. Ugeskr Laeger. 1963 Jun 21;125:890-2. Danish. PubMed PMID: 13970269.

5: MacAllister CG, Perdue BD. Endoscopic diagnosis of unilateral ectopic ureter in a yearling filly. J Am Vet Med Assoc. 1990 Sep 1;197(5):617-8. PubMed PMID: 2211312.

6: Bryant JS, Gausche-Hill M. When is red urine not hematuria?: A case report. J Emerg Med. 2007 Jan;32(1):55-7. PubMed PMID: 17239733.

7: Shargel L, Banijamali AR, Kuttab SH. Relationship between azo dye structure and rat hepatic azoreductase activity. J Pharm Sci. 1984 Feb;73(2):161-4. PubMed PMID: 6707875.

8: Gingell R, Bridges JW, Williams RT. The role of the gut flora in the metabolism of prontosil and neoprontosil in the rat. Xenobiotica. 1971 Mar;1(2):143-56. PubMed PMID: 5173017.

9: Carey PR, King RW. Neoprontosil binding to carbonic anhydrase. Reasonance Raman and other studies on the ionization behavior of the sulfonamide. Biochemistry. 1979 Jun 26;18(13):2834-8. PubMed PMID: 38830.

10: Thompson RB, Patchan MW. Lifetime-based fluorescence energy transfer biosensing of zinc. Anal Biochem. 1995 May 1;227(1):123-8. PubMed PMID: 7668370.

11: SCUDERI G, BELLOMIO S. [Comparative experimental clinical research on the effect of chloramphenicol, azosulfamides and penicillin in trachoma]. Arch Sci Med (Torino). 1951 Sep;92(3):152-74. Undetermined Language. PubMed PMID: 14904246.

12: Douglas KL, Walker RV. Use of Neo-Prontosil in Strangles. Can J Comp Med. 1939 Jun;3(6):166-9. PubMed PMID: 17647531; PubMed Central PMCID: PMC1702136.

13: Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 2017 Jan;179:204-222. doi: 10.1016/j.trsl.2016.08.002. Epub 2016 Aug 13. Review. PubMed PMID: 27591027; PubMed Central PMCID: PMC5718288.

14: Kendrick DB. TREATMENT OF GAS GANGRENE INFECTIONS IN GUINEA-PIGS WITH NEOPRONTOSIL, SULFANILAMIDE, AND SULFAPYRIDINE: AN EXPERIMENTAL STUDY. J Clin Invest. 1939 Sep;18(5):593-6. PubMed PMID: 16694690; PubMed Central PMCID: PMC434904.

15: Chung KT, Stevens SE Jr, Cerniglia CE. The reduction of azo dyes by the intestinal microflora. Crit Rev Microbiol. 1992;18(3):175-90. Review. PubMed PMID: 1554423.

16: Evelhoch JL, Bocian DF, Sudmeier JL. Evidence for direct metal-nitrogen binding in aromatic sulfonamide complexes of cadmium (II)-substituted carbonic anhydrases by cadmium-113 nuclear magnetic resonance. Biochemistry. 1981 Aug 18;20(17):4951-4. PubMed PMID: 6794601.

17: Petersen RL, Li TY, McFarland JT, Watters KL. Determination of ionization state by resonance Raman spectroscopy Sulfonamide binding to carbonic anhydrase. Biochemistry. 1977 Feb 22;16(4):726-31. PubMed PMID: 13824.

18: Osborne WR, Tashian RE. Dissociation constants for carbonic anhydrase--sulfonamide binding by high-performance liquid chromatography. Anal Biochem. 1984 Mar;137(2):302-6. PubMed PMID: 6428265.

19: Ericksson M, Catz C, Yaffe SJ. Effect of weanling malnutrition upon hepatic drug metabolism. Biol Neonate. 1975;27(5-6):339-51. PubMed PMID: 1174605.

20: Osborne WR, Tashian RE. The proteolytic degradation of normal and variant human carbonic anhydrase isozymes by alpha-chymotrypsin. J Biol Chem. 1981 Feb 10;256(3):1330-4. PubMed PMID: 6778879.